Status:
UNKNOWN
The Effect of Aromatherapy on COVID-19-induced Anxiety
Lead Sponsor:
Nutraceuticals Research Institute
Conditions:
Stress
Covid19
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the potential for a non-invasive sensory based intervention to reduce the stress associated with a COVID-19 diagnosis.
Detailed Description
After being informed about the study, participants who provide consent will be randomized to one of two groups. Participants will receive one of two aromas to inhale with one being active and the othe...
Eligibility Criteria
Inclusion
- Otherwise healthy
- Documented COVID-19 exposure, suspected infection, or diagnosed infection
- Has been tested for or diagnosed with COVID-19
- adults age 18-65 living in the US
- understands and agrees to comply with study procedures
- provides informed consent
Exclusion
- Smoker in household
- Pregnant or may become pregnant
- Difficulty breathing
- Pain or pressure in the chest
- Confusion
- Hospitalization
- Asthma, COPD, or other respiratory condition
- demonstrated inability to comply with study procedures
- has participated in an interventional clinical study within 31 days prior to enrollment
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04495842
Start Date
October 1 2020
End Date
March 31 2022
Last Update
August 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Franklin Health Research Center
Franklin, Tennessee, United States, 37067